Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Front Neurol ; 15: 1388306, 2024.
Article in English | MEDLINE | ID: mdl-38756218

ABSTRACT

Background: Functional near infrared spectroscopy (fNIRS) has developed rapidly in recent years, and there are more and more studies on fNIRS. At present, there is no bibliometric analysis of the top 100 most cited articles on fNIRS research. Objective: To identify the top 100 most cited articles on fNIRS and analyze those most fundamental and popular articles through bibliometric research methods. Methods: The literature on fNIRS of web of science from 1990 to 2023 was searched and the top 100 most cited articles were identified by citations. Use the bibliometrix package in R studio and VOSviewer for data analysis and plotting to obtain the output characteristics and citation status of these 100 most cited articles, and analyze research trends in this field through keywords. Results: A total of 9,424 articles were retrieved from web of science since 1990. The average citation number of the 100 articles was 457.4 (range from 260 to 1,366). Neuroimage published the most articles (n = 31). Villringer, A. from Leipzig University had the largest number of top 100 papers. Harvard University (n = 22) conducted most cited articles. The United States, Germany, Japan, and the United Kingdom had most cited articles, respectively. The most common keywords were near-infrared spectroscopy, activation, cerebral-blood-flow, brain, newborn-infants, oxygenation, cortex, fMRI, spectroscopy. The fund sources mostly came from National Institutes of Health Unitd States (NIH) and United States Department of Health Human Services (n = 28). Conclusion: Neuroimage was the most popular journal. The top countries, institutions, and authors were the United States, Harvard University, and Villringer, A., respectively. Researchers and institutions from North America and Europe contributed the most. Near-infrared spectroscopy, activation, cerebral-blood-flow, brain, newborn-infants, oxygenation, cortex, fmri, spectroscopy, stimulation, blood-flow, light-propagation, infants, tissue comprise the future research directions and potential topic hotspots for fNIRS.

2.
Trials ; 24(1): 199, 2023 Mar 17.
Article in English | MEDLINE | ID: mdl-36932375

ABSTRACT

BACKGROUND: Neurogenic detrusor overactivity (NDO) is a serious and common complication after spinal cord injury, affecting patients' quality of life seriously. Therefore, we developed this research protocol to evaluate the efficacy of repetitive functional magnetic stimulation (rFMS) in the sacral nerve in patients with neurogenic detrusor overactivity (NDO) after suprasacral spinal cord injury (SCI) and provide more options for rFMS in treating NDO after suprasacral SCI. METHODS: This study is a single-center, randomized, parallel-group clinical trial. We will recruit the patients with NDO after suprasacral SCI in the Rehabilitation Department of the Affiliated Hospital of Southwest Medical University from September 2022 to August 2023. They will be assigned to the rFMS group and the sham stimulation group randomly. The sample size is 66, with 33 patients in each group. The rFMS group will receive real rFMS treatment of the sacral nerve (100% stimulation intensity, 5 Hz, 20 min each time, five times a week), and the sham group will receive sham stimulation. Both groups will receive similar treatment strategies, including medication, standard urine management, acupuncture treatment, and health education. The bladder compliance (bladder capacity/detrusor pressure) and pudendal nerve electromyography will be evaluated at baseline, 8th week of treatment. The residual volume of the bladder and bladder diary will be recorded once a week during 8 weeks of treatments. SCI-QOL and NBSS will be evaluated at baseline, the 4th and 8th week of treatment. In addition, the above assessments will be followed up at 8 weeks after the end of treatment. DISCUSSION: It is expected that the bladder function, symptoms, and quality of life might be significantly improved after rFMS of the sacral nerve. TRIAL REGISTRATION: The China Clinical Trials Registry has approved this study, registration number: ChiCTR2100045148. Registered on April 7, 2021.


Subject(s)
Spinal Cord Injuries , Urinary Bladder, Neurogenic , Urinary Bladder, Overactive , Humans , Quality of Life , Urinary Bladder, Neurogenic/diagnosis , Urinary Bladder, Neurogenic/etiology , Urinary Bladder, Neurogenic/therapy , Spinal Cord Injuries/complications , Spinal Cord Injuries/diagnosis , Urinary Bladder, Overactive/diagnosis , Urinary Bladder, Overactive/etiology , Urinary Bladder, Overactive/therapy , Magnetic Phenomena , Urodynamics , Treatment Outcome , Randomized Controlled Trials as Topic
3.
BMJ Open ; 12(3): e053476, 2022 03 11.
Article in English | MEDLINE | ID: mdl-35277402

ABSTRACT

INTRODUCTION: Neuropathic pain is one of the common complications of spinal cord injuries (SCI), which will slow down the recovery process and result in lower quality of life. Previous studies have shown that repeated transcranial magnetic stimulation (rTMS) of the motor cortex (M1) can reduce the average pain and the most severe pain of neuropathic pain after SCI. The dorsolateral prefrontal cortex (DLPFC) area is a common target of rTMS. Recently, a few studies found that rTMS of DLPFC may relieve the neuropathic pain of SCI. Compared with the M1 area, the efficacy of rTMS treatment in the DLPFC area in improving neuropathic pain and pain-related symptoms in patients with SCI is still unclear. Therefore, our study aims to evaluate the non-inferiority of rTMS in the DLPFC vs M1 in patients with neuropathic pain after SCI, in order to provide more options for rTMS in treating neuropathic pain after SCI. METHODS AND ANALYSIS: We will recruit 50 subjects with neuropathic pain after SCI. They will be randomly assigned to the DLPFC- rTMS and M1-rTMS groups and be treated with rTMS for 4 weeks. Except for the different stimulation sites, the rTMS treatment programmes of the two groups are the same: 10 Hz, 1250 pulses, 115% intensity threshold, once a day, five times a week for 4 weeks. VAS, simplified McGill Pain Questionnaire, Spinal Cord Injury Pain Date Set, Pittsburgh Sleep Quality Index and Hamilton Anxiety Scale will be evaluated at baseline, second week of treatment, fourth week of treatment and 4 weeks after the end of treatment. And VAS change will be calculated. ETHICS AND DISSEMINATION: The Ethics Committee of the Affiliated Hospital of Southwest Medical University has approved this trial, which is numbered KY2020041. Written informed consent will be provided to all participants after verification of the eligibility criteria. The results of the study will be published in peer-reviewed publications. TRIAL REGISTRATION NUMBER: ChiCTR2000032362.


Subject(s)
Motor Cortex , Neuralgia , Spinal Cord Injuries , Dorsolateral Prefrontal Cortex , Humans , Neuralgia/complications , Neuralgia/therapy , Quality of Life , Randomized Controlled Trials as Topic , Spinal Cord Injuries/complications , Spinal Cord Injuries/therapy , Transcranial Magnetic Stimulation/methods , Treatment Outcome
4.
Disabil Rehabil ; 44(2): 177-188, 2022 Jan.
Article in English | MEDLINE | ID: mdl-32419508

ABSTRACT

PURPOSE: To determine whether shock wave therapy could improve symptoms and hand function in patients with carpal tunnel syndrome. MATERIALS AND METHODS: Medline, Embase, Physiotherapy Evidence Database, the Cochrane Central Register of Controlled Trials, OpenGrey, CNKI, VIP, Wang Fang databases, and China Biological Medicine were searched, from inception to December 2019. RESULTS: Ten trials involving 433 patients (501 wrists) were included in this systematic review. The shock wave therapy was observed to have a significant effect on pain relief (MD: -0.60, 95% CI: -1.16 to -0.05, p = 0.03), syndrome alleviation (MD: -2.26, 95% CI: -3.24 to -1.27, p < 0.00001) and functional recovery (MD: -1.25 95% CI: -2.08 to -0.43, p = 0.003) among the carpal tunnel syndrome patients. As revealed by the subgroup analysis, radial shock wave therapy made a significant difference in pain relief, syndrome alleviation, and functional recovery (p < 0.05). Focused shock wave had no significant effect on pain relief, syndrome alleviation, and functional recovery (p > 0.05). CONCLUSION: Shock wave therapy could be conductive to improve syndrome and hand function for carpal tunnel syndrome patients.Implications for rehabilitationShock wave therapy is beneficial for alleviating syndrome and improving hand function of carpal tunnel syndrome patients.Radial shock wave therapy seems superior to focused shock wave therapy on syndrome alleviation and functional recovery of hand in carpal tunnel syndrome patients.


Subject(s)
Carpal Tunnel Syndrome , Extracorporeal Shockwave Therapy , Carpal Tunnel Syndrome/diagnosis , Carpal Tunnel Syndrome/therapy , Humans , Pain Management , Recovery of Function , Treatment Outcome
5.
Arch Osteoporos ; 15(1): 130, 2020 08 17.
Article in English | MEDLINE | ID: mdl-32804292

ABSTRACT

Asian countries have made great progress in the osteoporosis research over the past 20 years. Mainland China has a significant increase in the number of articles. The scientific influence of Japan ranked by citations was leading in Asia. Indian researchers published fewer articles on osteoporosis, but the overall citation was quite well. PURPOSE: To analyze the quantity and quality of literature regarding osteoporosis from the Asian countries/regions. METHODS: Data were obtained from the Web of Science (WoS) Core Collection on May 4, 2020. Qualitative and quantitative analysis was conducted based on WoS. Keywords analysis was performed using VosView software. RESULTS: The core countries/regions in Asia in the osteoporosis research included the Mainland China (MC), Japan, South Korea, Turkey, Taiwan, India, and Iran. The core countries/regions published 4798 papers, which accounted for 33.8% of the total globally. The MC with 2242 literature and Japan with 971 were ranked second and fourth worldwide. Over the past decade, MC has published the most articles and increased dramatically. Japan had the highest mean citations and the highest mean citation density. The country with the most publications in the top ten popular osteoporosis-related journals was Japan. The top institutional from the MC, Taiwan, South Korea, and Japan published the most articles. The top authors with the most articles were from Japan and MC. Top institutions and authors from Japan, MC, and India led the way in citations. The core countries/regions had more frequent cooperation with the USA, the UK, and Canada compared with the limited cooperation among Asian countries. Osteoporosis research in Asia relies heavily on public funding and pharmaceutical companies. Keywords for these studies have changed over the past 20 years. CONCLUSIONS: Asian countries have made progress in the osteoporosis research over the past 20 years. The MC has a significant increase in the number of articles. The scientific influence of Japan ranked by citations was leading in Asia. Indian researchers published fewer articles on osteoporosis, but the overall quality was quite well. The core Asian countries/regions should strengthen in-depth cooperation in the future.


Subject(s)
Bibliometrics , Osteoporosis/ethnology , Periodicals as Topic , Research/trends , Asia , Humans , Journal Impact Factor , Osteoporosis/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...